Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Sangamo Therapeutics (SGMO) has a market cap of $0.17 billion USD. According to our data, Sangamo Therapeutics is ranked No.7163 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.17 B |
-22.06%
|
| Dec 31, 2024 | $0.21 B |
88.89%
|
| Dec 29, 2023 | $0.11 B |
-82.80%
|
| Dec 30, 2022 | $0.66 B |
-58.13%
|
| Dec 31, 2021 | $1.56 B |
-51.95%
|
| Dec 31, 2020 | $3.26 B |
86.50%
|
| Dec 31, 2019 | $1.75 B |
-27.09%
|
| Dec 31, 2018 | $2.40 B |
-30.00%
|
| Dec 29, 2017 | $3.42 B |
437.70%
|
| Dec 30, 2016 | $0.64 B |
-66.59%
|
| Dec 31, 2015 | $1.90 B |
-39.97%
|
| Dec 31, 2014 | $3.17 B |
9.50%
|
| Dec 31, 2013 | $2.90 B |
131.11%
|
| Dec 31, 2012 | $1.25 B |
111.62%
|
| Dec 30, 2011 | $0.59 B |
-57.23%
|
| Dec 31, 2010 | $1.39 B |
12.16%
|
| Dec 31, 2009 | $1.24 B |
70.11%
|
| Dec 31, 2008 | $0.73 B |
-73.27%
|
| Dec 31, 2007 | $2.72 B |
97.27%
|
| Dec 29, 2006 | $1.38 B |
63.77%
|
| Dec 30, 2005 | $0.84 B |
-32.83%
|
| Dec 31, 2004 | $1.25 B |
9.69%
|
| Dec 31, 2003 | $1.14 B |
81.73%
|
| Dec 31, 2002 | $0.63 B |
-67.77%
|
| Dec 31, 2001 | $1.95 B |
-52.10%
|
| Dec 29, 2000 | $4.07 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
USA
|
 Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Illumina
ILMN
|
$11.80 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
USA
|
 10x Genomics
TXG
|
$1.00 B |
0.115 B
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
| Market Cap | = | SGMO Stock Price | * | SGMO Shares Outstanding |
| = | $0.74 | * | 0.22 B | |
| = | $0.17 B |